Vivani Medical Inc (VANI)

$1.27 +0.01 (0.79%)
Market Cap 91.92M
Revenue (ttm) 0.00
Net Income (ttm) -23.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 75,500
Avg Vol 188,734
Day's Range N/A - N/A
Shares Out 72.95M
Stochastic %K 33%
Beta 3.07
Analysts Strong Sell
Price Target $4.00

Company Profile

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management i...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 506 8462
Address:
1350 South Loop Road, Alameda, United States
horizon183
horizon183 Jan. 16 at 10:59 PM
$VANI when is this breaking off cortagent?
0 · Reply
oneyedjacks
oneyedjacks Jan. 14 at 3:08 AM
$ALT $VANI This combo would dominate the MASH market with superior efficacy and patient compliance. Listening? $MDGL $PFE
0 · Reply
oneyedjacks
oneyedjacks Jan. 14 at 2:58 AM
$ALT $VANI These two need talk $MDGL into a threesome. Best bet for patient compliance.
1 · Reply
BC322032
BC322032 Jan. 13 at 9:44 PM
$VANI
0 · Reply
Earl40
Earl40 Jan. 6 at 12:44 PM
$VANI 2 years later and this POS is right where it started LMAO
0 · Reply
Bearbull_Baggins
Bearbull_Baggins Dec. 31 at 4:52 PM
$VANI Trying to figure out if insider buys are bullish, or if its just a strategy for them to have shares for the Cortigent spin off. Didn't they say VANI shareholders will have some stake in the new ticker? 🤔 probably overthinking it
1 · Reply
RatioTrendMechanic
RatioTrendMechanic Dec. 27 at 7:13 AM
$VANI Momentum persists only for businesses proving consistency quarter to quarter. Balance‑sheet flexibility may prove significant. Transparency improvements could narrow valuation spreads. Ultimately, disciplined delivery will shape the outcome.
0 · Reply
wolfcyd3
wolfcyd3 Dec. 26 at 8:55 PM
$VANI added
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 24 at 11:33 AM
$VANI Share Price: $1.38 Contract Selected: May 15, 2026 $1.0 Calls Buy Zone: $0.38 – $0.47 Target Zone: $0.63 – $0.77 Potential Upside: 56% ROI Time to Expiration: 141 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Bagholderruined
Bagholderruined Dec. 20 at 2:34 PM
$VANI I emailed IR and they confirmed they still have paperwork filed for the spinoff. That’s a positive. Insiders buying stock rather than the company taking loans is a huge positive. I still feel we are in loading phase. Every dip is an opportunity.
2 · Reply
Latest News on VANI
Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 7:45 AM EST - 2 months ago

Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results

Vivani Medical, Inc. Announces Closing of Common Stock Offering

Oct 28, 2025, 4:05 PM EDT - 2 months ago

Vivani Medical, Inc. Announces Closing of Common Stock Offering

Vivani Medical, Inc. Announces Pricing of Common Stock Offering

Oct 26, 2025, 7:15 PM EDT - 2 months ago

Vivani Medical, Inc. Announces Pricing of Common Stock Offering

Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off

Oct 3, 2025, 8:30 AM EDT - 3 months ago

Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025

Sep 24, 2025, 9:15 AM EDT - 4 months ago

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025

Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders

Sep 17, 2025, 8:30 AM EDT - 4 months ago

Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders

Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management

Sep 4, 2025, 8:30 AM EDT - 4 months ago

Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management

Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025

Aug 20, 2025, 8:30 AM EDT - 5 months ago

Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 4:20 PM EDT - 5 months ago

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

I Missed The Quantum Rally - I Won't Miss The Next One

May 20, 2025, 5:47 AM EDT - 8 months ago

I Missed The Quantum Rally - I Won't Miss The Next One

AMSC AUTL CAPR CLPT EDIT NTLA VERV

Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

May 13, 2025, 4:30 PM EDT - 8 months ago

Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

Vivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop

May 7, 2025, 8:30 AM EDT - 9 months ago

Vivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop

Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity

Apr 15, 2025, 8:30 AM EDT - 9 months ago

Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 31, 2025, 7:30 AM EDT - 10 months ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Vivani Medical Announces $8.25M Private Placement Equity Financing

Mar 27, 2025, 7:32 AM EDT - 10 months ago

Vivani Medical Announces $8.25M Private Placement Equity Financing

Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing

Mar 26, 2025, 7:30 AM EDT - 10 months ago

Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing

Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025

Mar 24, 2025, 8:30 AM EDT - 10 months ago

Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults

Mar 13, 2025, 7:30 AM EDT - 11 months ago

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults

Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business

Mar 12, 2025, 8:30 AM EDT - 11 months ago

Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business

EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value

Mar 12, 2025, 8:00 AM EDT - 11 months ago

EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value

CRGT

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Dec 19, 2024, 8:30 AM EST - 1 year ago

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

Dec 4, 2024, 8:30 AM EST - 1 year ago

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Nov 13, 2024, 8:30 AM EST - 1 year ago

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

Oct 22, 2024, 8:30 AM EDT - 1 year ago

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Sep 26, 2024, 8:30 AM EDT - 1 year ago

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Sep 23, 2024, 8:57 AM EDT - 1 year ago

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 28, 2024, 7:10 PM EDT - 1 year ago

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Aug 13, 2024, 4:05 PM EDT - 1 year ago

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Jul 11, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Jun 13, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

May 28, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

May 13, 2024, 4:45 PM EDT - 1 year ago

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

Vivani Medical to Present at TIDES Conference 2024

May 9, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical to Present at TIDES Conference 2024

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 26, 2024, 8:30 AM EDT - 1 year ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Mar 6, 2024, 8:00 AM EST - 2 years ago

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

Mar 1, 2024, 7:49 AM EST - 2 years ago

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

Vivani Medical (VANI) stock price surged: is it a good buy?

Feb 29, 2024, 7:25 AM EST - 2 years ago

Vivani Medical (VANI) stock price surged: is it a good buy?

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

Feb 28, 2024, 8:30 AM EST - 2 years ago

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

Vivani Medical Provides Business Update and Reports Third Quarter Financial Results

Nov 14, 2023, 6:00 AM EST - 2 years ago

Vivani Medical Provides Business Update and Reports Third Quarter Financial Results

Vivani Medical to Present at BIO Investor Forum

Oct 16, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Present at BIO Investor Forum

Vivani Medical to Present at the Boulder Peptide Symposium

Sep 7, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Present at the Boulder Peptide Symposium

Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10

Sep 5, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10

Vivani Medical Reports Second Quarter Financial Results and Provides Business Update

Aug 14, 2023, 5:45 PM EDT - 2 years ago

Vivani Medical Reports Second Quarter Financial Results and Provides Business Update

Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System

Jul 11, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System

Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

Jun 14, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

Vivani Medical Reports First Quarter Financial Results and Provides Business Update

May 15, 2023, 6:15 AM EDT - 2 years ago

Vivani Medical Reports First Quarter Financial Results and Provides Business Update

Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent's Ongoing Orion Clinical Study

Apr 4, 2023, 6:00 AM EDT - 3 years ago

Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent's Ongoing Orion Clinical Study

Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Mar 31, 2023, 2:50 PM EDT - 3 years ago

Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

Mar 21, 2023, 6:00 AM EDT - 3 years ago

Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

horizon183
horizon183 Jan. 16 at 10:59 PM
$VANI when is this breaking off cortagent?
0 · Reply
oneyedjacks
oneyedjacks Jan. 14 at 3:08 AM
$ALT $VANI This combo would dominate the MASH market with superior efficacy and patient compliance. Listening? $MDGL $PFE
0 · Reply
oneyedjacks
oneyedjacks Jan. 14 at 2:58 AM
$ALT $VANI These two need talk $MDGL into a threesome. Best bet for patient compliance.
1 · Reply
BC322032
BC322032 Jan. 13 at 9:44 PM
$VANI
0 · Reply
Earl40
Earl40 Jan. 6 at 12:44 PM
$VANI 2 years later and this POS is right where it started LMAO
0 · Reply
Bearbull_Baggins
Bearbull_Baggins Dec. 31 at 4:52 PM
$VANI Trying to figure out if insider buys are bullish, or if its just a strategy for them to have shares for the Cortigent spin off. Didn't they say VANI shareholders will have some stake in the new ticker? 🤔 probably overthinking it
1 · Reply
RatioTrendMechanic
RatioTrendMechanic Dec. 27 at 7:13 AM
$VANI Momentum persists only for businesses proving consistency quarter to quarter. Balance‑sheet flexibility may prove significant. Transparency improvements could narrow valuation spreads. Ultimately, disciplined delivery will shape the outcome.
0 · Reply
wolfcyd3
wolfcyd3 Dec. 26 at 8:55 PM
$VANI added
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 24 at 11:33 AM
$VANI Share Price: $1.38 Contract Selected: May 15, 2026 $1.0 Calls Buy Zone: $0.38 – $0.47 Target Zone: $0.63 – $0.77 Potential Upside: 56% ROI Time to Expiration: 141 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Bagholderruined
Bagholderruined Dec. 20 at 2:34 PM
$VANI I emailed IR and they confirmed they still have paperwork filed for the spinoff. That’s a positive. Insiders buying stock rather than the company taking loans is a huge positive. I still feel we are in loading phase. Every dip is an opportunity.
2 · Reply
MGeronimo
MGeronimo Dec. 20 at 2:59 AM
$VANI $2 million insider buy
0 · Reply
lowInCash
lowInCash Dec. 19 at 1:05 AM
$VANI this insider buy is just a form of financing for this company? There aren’t any other insiders buying except for chairman?
0 · Reply
Mendoza_333
Mendoza_333 Dec. 16 at 5:43 PM
$VANI iv - minus 32 on the day!!! Let's go - don't be late!!!
0 · Reply
Bagholderruined
Bagholderruined Dec. 16 at 2:52 PM
$VANI I feel like I’m behind on loading this up. Mr. Williams nearing 30million shares and every time he has had opportunity to buy he goes balls in!!
0 · Reply
millionaire2021
millionaire2021 Dec. 16 at 2:15 PM
$VANI gregg now controls over 41% of the company !
1 · Reply
millionaire2021
millionaire2021 Dec. 16 at 2:13 PM
$VANI almost 30 million shares owned by Gregg!! Don’t know what to make out of it
0 · Reply
wolfcyd3
wolfcyd3 Dec. 16 at 2:09 PM
$VANI director bought another 1.7 million shares https://www.sec.gov/Archives/edgar/data/1624919/000175392625001892/0001753926-25-001892-index.htm
0 · Reply
ToniesPick
ToniesPick Dec. 16 at 9:25 AM
$VANI how about $1.75 next?
0 · Reply
Mendoza_333
Mendoza_333 Dec. 16 at 2:40 AM
$VANI common - give the fans $2 - at least!!!
0 · Reply
BC322032
BC322032 Dec. 11 at 9:11 PM
$VANI Added. Thank you!
0 · Reply
Earl40
Earl40 Dec. 10 at 9:12 PM
$VANI This POS is still in the $1 range? lol
0 · Reply
66Harry
66Harry Dec. 9 at 4:19 PM
$VANI Any news in separating two definitions ?
0 · Reply